Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Aeglea BioTherapeutics buys Spyre Therapeutics to revolutionize IBD treatment Aeglea BioTherapeutics, a Nasdaq-listed company, has acquired Spyre Therapeutics, a private biotech company dedicated to advancing a promising… byPallavi MadhirajuJune 25, 2023